Ubs Group Ag Neuro Sense Therapeutics Ltd. Transaction History
Ubs Group Ag
- $582 Billion
- Q4 2025
A detailed history of Ubs Group Ag transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 30,871 shares of NRSN stock, worth $30,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,871
Previous 14,659
110.59%
Holding current value
$30,253
Previous $18,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding NRSN
# of Institutions
10Shares Held
293KCall Options Held
0Put Options Held
0-
Squarepoint Ops LLC New York, NY95.4KShares$93,4670.0% of portfolio
-
Morgan Stanley New York, NY66.4KShares$65,0720.0% of portfolio
-
Meitav Dash Investments LTD40KShares$39,2000.0% of portfolio
-
Two Sigma Investments, LP New York, NY21.1KShares$20,6640.0% of portfolio
-
Commonwealth Equity Services, LLC21.1KShares$20,6580.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $11.4M